BMA vs GGAL: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of August 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

Reading it: GGAL is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. BMA and GGAL share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined BMA and GGAL exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

Banco Macro (NYSE: BMA) is one of the largest privately owned banks in Argentina, with a national branch footprint and a strong presence outside Buenos Aires in the country's interior provinces. Each ADR represents ten Class B common shares. The bank offers retail and commercial banking, lending to individuals and small and medium businesses, deposits, payments, and, increasingly, digital finance (it took a 50% stake in the Personal Pay wallet to tap Telecom's customer base). It has historically run high capital ratios and holds roughly a mid-teens share of the Argentine banking system.

Full BMA guide

Grupo Financiero Galicia is an Argentine financial holding company whose flagship subsidiary, Banco Galicia, is one of the country's largest private-sector banks by loans and deposits. The group also owns Naranja X (a consumer credit-card and fintech business), Fondos Fima (asset management), and Galicia Seguros (insurance), giving it exposure across lending, payments, investing, and insurance. In 2024 it acquired HSBC's Argentine operations, rebranded as Galicia Más, which expanded its scale in retail and corporate banking. The shares trade in the US as an ADR on Nasdaq under the ticker GGAL.

Full GGAL guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• BMA drivers: Argentina disinflation and rate normalization; Credit growth off a low base.
• GGAL drivers: Argentina macro normalization; Credit growth off a low base.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: Argentina carries some of the highest macro risk of any major economy, and BMA concentrates that risk in a single stock. For GGAL, the single largest risk is Argentina itself: currency devaluation, capital controls, renewed inflation, or a stalled reform program can erase US-dollar returns for ADR holders regardless of how the bank operates.

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick BMA if you believe its drivers more; GGAL if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the BMA and GGAL guides.

BMA. Argentine bank financials are reported in inflation-adjusted pesos, which makes reported figures hard to compare across periods and against US peers. ROE has compressed sharply from historical highs as rates and inflation moderated, and Q4 2025 was dented by restructuring charges. After a strong share rally, some valuation screens flagged the ADR as trading well above estimated fair value.

GGAL. GGAL reports under Argentine hyperinflation accounting (IAS 29), which makes headline net income and price-to-earnings multiples noisy and hard to compare year to year. Investors often look instead at return on equity, efficiency, loan growth, and asset quality, plus the group's book value in US-dollar terms. Because the ADR carries heavy currency and country risk, the stock frequently trades on Argentina's macro headlines more than on any single quarter.

Headline figures (approximate, JULY 2026): BMA shows recent adr price ~$100 range in early 2026, q2 2025 net income ~ARS 149.5B, 9m 2025 net income ~ARS 176.7B (down ~35% YoY), q4 2025 net income ~ARS 100B (down ~26% YoY); GGAL shows market cap ~$8.5B, q1 2026 net income ~ARS 66.5B (down ~66% YoY), return on equity (roae) ~3.2% in Q1 2026; ~10-11% guided for 2026, efficiency ratio ~39.9%.

BMA and GGAL are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined BMA and GGAL exposure against your real portfolio. It is not an investment adviser.